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Long-term antibiotic use generates pan-resistant super pathogens. Anti-infective compounds that selectively disrupt
virulence pathways without affecting cell viability may be used to efficiently combat infections caused by these
pathogens. A candidate target pathway is quorum sensing (QS), which many bacterial pathogens use to coordinately
regulate virulence determinants. The Pseudomonas aeruginosa MvfR-dependent QS regulatory pathway controls the
expression of key virulence genes; and is activated via the extracellular signals 4-hydroxy-2-heptylquinoline (HHQ) and
3,4-dihydroxy-2-heptylquinoline (PQS), whose syntheses depend on anthranilic acid (AA), the primary precursor of 4-
hydroxy-2-alkylquinolines (HAQs). Here, we identified halogenated AA analogs that specifically inhibited HAQ
biosynthesis and disrupted MvfR-dependent gene expression. These compounds restricted P. aeruginosa systemic
dissemination and mortality in mice, without perturbing bacterial viability, and inhibited osmoprotection, a
widespread bacterial function. These compounds provide a starting point for the design and development of
selective anti-infectives that restrict human P. aeruginosa pathogenesis, and possibly other clinically significant
pathogens.
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Introduction
Current treatment of human bacterial infections depends
on bactericidal and bacteriostatic antibiotics whose long-
term effectiveness is limited by the development of drug
resistance and can devastate the host commensal microbial
community. An alternative approach to combat bacterial
pathogens is the use of anti-infective drugs that selectively
disrupt pathways that mediate virulence, such as regulation of
pathogenesis genes [1]. Compounds that do not disrupt
survival or growth should be less likely to generate resistance
than traditional antibiotics. Ideally, these reagents should not
disrupt bacterial and host metabolism, and should not cause
harmful side effects. To date, the development of such drugs
has been limited [2–4]. Here, we validated the utility of
selective anti-infective compounds to combat infections
caused by the opportunistic human pathogen Pseudomonas
aeruginosa. This ubiquitous Gram-negative bacterium readily
develops antibiotic resistance, and it is a principal agent of
deleterious and fatal infections in immunocompromised
patients and in pan-antibiotic-resistant outbreaks [5–7]. As
such, identiﬁcation of compounds that selectively disrupt P.
aeruginosa pathogenesis should lead to improved clinical
treatments of human P. aeruginosa infections.
Bacterial pathogens express certain virulence genes at high
cell density. Since this population-dependent regulation
controls virulence, but not viability, it is a potential Achilles’
heel through which to attack pathogenicity [3,4,8,9]. Many
differentiated bacterial behaviors are similarly triggered in
response to cell density, and such coordinated intercellular
regulation is achieved via quorum sensing (QS), a chemical
communication system mediated by small extracellular signal
molecules [10]. Signal synthesis is autoinducible, and as such,
signal molecule concentration rises as the population density
increases until a critical threshold concentration is reached,
which then triggers expression of certain sets of genes.
However, further studies suggest that the activation of most
QS-controlled genes is not solely triggered by the accumu-
lation of signal but also requires additional factors [11,12].
The archetypal QS system uses an acyl homoserine lactone
(AHL) intercellular signal that, when the minimum threshold
is attained, binds to and activates its cognate LuxR-type
transcriptional regulator [13]. This coligand–protein complex
then binds as a homodimer to a ‘‘lux-box’’ sequence within
the promoters of target loci, including the AHL synthase
gene, to activate or repress their transcription [14,15].
Signiﬁcantly, QS signal molecules occur in infection sites,
suggesting that QS inhibition might disrupt virulence [16,17].
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more QS components, including signal synthesis, signal
regulator binding, or synthase or regulator stability. Although
compounds have indeed been identiﬁed that inhibit QS in
infection sites, to date none have been shown to combat
infection effectively. For example, certain AHL derivatives
enhance bacterial clearance in lung, and delay death in
infected mice, yet fail to reduce overall mortality [18–20].
Similarly, furanones that stimulate LuxR turnover [21] give
similar results, yet again do not reduce overall mortality.
Three distinct regulatory pathways have been identiﬁed
that control QS-dependent expression in P. aeruginosa. Two of
these systems utilize the LuxR regulatory proteins LasR and
RhlR and their cognate AHL autoinducers and synthases [22].
In contrast, the third system utilizes a LysR-type transcrip-
tional regulator (LTTR), MvfR, which is activated by its
coligands, 4-hydroxy-2-heptylquinoline (HHQ) and 3,4-dihy-
droxy-2-heptylquinoline (PQS). Although both HHQ and
PQS bind to and activate MvfR, PQS is 100-fold more potent
than HHQ [23]. Interestingly, in contrast to the in vitro
ﬁndings, HHQ is highly produced in vivo, where it is not fully
converted into PQS [23]. These coligands are part of a large
family of 4-hydroxy-2-alkylquinolines (HAQs) that comprise
ﬁve distinct congener series, including N-oxides, such as 4-
hydroxy-2-heptylquinoline N-oxide (HQNO) and dihydroxy-
lated derivatives [24–26]. Once MvfR is activated, it binds to a
‘‘lys-box’’ in its target promoters [23,27,28]. MvfR coligand
synthesis is also autoinducible [23,29,30]. Production of the
coligands is controlled by MvfR, which regulates the
production of multiple QS-regulated virulence factors,
including pyocyanin, hydrogen cyanide, elastase, and lectins
[25,29]. mvfR
  mutant cells have greatly reduced pathogenic-
ity in several infection models [31], yet sustain wild-type
viability. The attenuated virulence of lasR
  mutant cells is
mediated, at least in part, via MvfR [32]. Consequently,
selective inhibition of MvfR/HAQ regulation should restrict
P. aeruginosa pathogenesis, but not cell viability. Such selective
inhibition would also interfere with the ability of P. aeruginosa
cells to intercept host stress molecules required to activate P.
aeruginosa virulence factors via MvfR and the HAQ signaling
molecules PQS and HHQ [33]. Other important bacterial
pathogens, such as Burkholderia species, also synthesize HAQs
[34], which suggests that compounds that selectively inhibit
HAQ production could be used as anti-infectives against
other pathogens beyond P. aeruginosa.
MvfR coligand synthesis is essential for MvfR activation.
This synthesis requires two MvfR-regulated operons: phnAB
and pqsA-D.T h eo p e r o nphnAB directs production of
anthranilic acid (AA), which, in conjunction with ß-keto fatty
acids, is the primary HAQ precursor; while pqsA-D directs
production of the HAQ congener family [26,35,36]. Also, pqsH
directs the ﬁnal HHQ to PQS conversion. An early step in
HAQ biosynthesis is hypothesized to be formation of the
quinoline 3–4 carbon bond (see Figure 1B) via activation of
the AA carbonyl that then reacts with the ß-keto fatty acid
methylene. PqsA encodes a predicted coenzyme A ligase, and
such ligases can activate aromatic carboxylic acid compounds
[37]. According to this scheme, AA analogs that compete with
AA for the PqsA protein should inhibit HHQ and PQS
synthesis, but not viability, and consequently restrict MvfR
activation and bacterial pathogenesis. Here, we identiﬁed
halogenated AA analogs that speciﬁcally inhibited HAQ
biosynthesis in both P. aeruginosa and Burkholderia thailandensis
cells, disrupted MvfR-dependent gene expression, and re-
programmed the expression of both QS-dependent and QS-
independent genes. Signiﬁcantly, these reagents restricted P.
aeruginosa virulence in mice and increased host survival,
without perturbing bacterial viability. In addition, they
reduced osmoprotection, an environment-related cell re-
sponse common to many human bacterial pathogens. These
compounds provide a starting point for the design and
development of selective anti-infective drugs that restrict
human–P. aeruginosa pathogenesis, and also possibly other
signiﬁcant pathogens.
Results
Identification of Halogenated AA Analogs That Inhibit
HHQ and PQS Synthesis
The AA analog methylanthranilate (MA; Figure 1A) has
been previously shown to reduce P. aeruginosa PQS levels [38].
Nevertheless, MA is a poor candidate anti-infective, as 1.5 mM
MA only partially reduced the levels of HHQ and PQS, while
those of HAQ N-oxides were unaffected (Figure 2). Figure 1A
presents the ﬁve AA analogs tested that carry a ﬂuorine or
chlorine atom ortho or para to the AA carbonyl group: 2-
amino-5-ﬂuorobenzoic acid (5FABA), 2-amino-4-ﬂuoroben-
zoic acid (4FABA), 2-amino-6-ﬂuorobenzoic acid (6FABA), 2-
amino-6-chlorobenzoic acid (6CABA), and 2-amino-4-chlor-
obenzoic acid (4CABA). These analogs were chosen because
the electron-withdrawing effects of the halogen atoms should
restrict formation of an activated carbonyl such as a CoA
ester, and thus synthesis of the second aromatic ring of the
HAQ quinoline backbone would be prevented (Figure 1B).
However, we cannot exclude the possibility of a steric
hindrance effect or the result of an interaction of the
halogen with some residues in or near the active site of PqsA
(see below). Our results showed that 6FABA, 6CABA, and
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Author Summary
Current treatments of human bacterial infections depend on
antibiotics, whose long-term effectiveness is limited as they select
for multidrug-resistant pathogens. An alternative approach that is
likely to limit the development of bacterial super pathogens is to
selectively disrupt bacterial virulence mechanisms without affecting
bacterial viability. Quorum sensing (QS), a highly regulated bacterial
communication system, is a promising candidate target because it is
used by numerous pathogens to stimulate and coordinate the
expression of many virulence determinants, and its disruption does
not affect bacterial cell viability. We have identified three
compounds that efficiently inhibited the synthesis of molecules
required for the activation of the human opportunistic pathogen
Pseudomonas aeruginosa MvfR-dependent QS regulatory pathway
that controls the expression of key virulence genes. We showed that
prevention of MvfR pathway activation disrupted MvfR-dependent
gene expression, and limited P. aeruginosa infection in mice, without
perturbing bacterial viability. In addition, the compounds identified
limited the ability of a number of bacterial pathogens to tolerate
salt, a widespread bacterial function, and possibly other functions
relevant to pathogenesis. These compounds provide a starting point
for the design and development of selective anti-infectives that
restrict human P. aeruginosa pathogenesis, and possibly other
clinically significant pathogens.4CABA, but not 5FABA and 4FABA, greatly reduced the
levels of HHQ, PQS, and HQNO, which are representative
congeners of the three principal HAQ series, in PA14
cultures (Figure 2; unpublished data). Furthermore, no
chloro-HAQs were detected with 4CABA or 6CABA, and
only traces of halogenated N-oxides were detected in the
presence of 6FABA (unpublished data), indicating that these
halogenated AA analogs were not incorporated into HAQs.
Also, up to 6 mM 6FABA or 6CABA, and up to 1.5 mM
4CABA did not signiﬁcantly perturb PA14 growth kinetics
(Figure S1). Thus, these concentrations were used in all
subsequent experiments, unless noted otherwise.
The AA Analogs Reprogram P. aeruginosa Gene
Expression and Inhibit the MvfR Regulon
The AA analogs 6FABA, 6CABA, and 4CABA markedly
reprogram global gene expression in PA14 cells at late
exponential growth, when many virulence-related genes are
most highly expressed. Comparing the whole-genome tran-
scriptome proﬁle of control cells to the proﬁles of cells grown
in the presence of 6FABA, 6CABA, or 4CABA showed that
354, 618, and 683 genes, respectively, were differentially
expressed in response to these compounds (Tables 1 and S1),
or 6.2%, 10.8%, and 12% of the 5,684 predicted ORFs assayed
by the P. aeruginosa Genechip array. As a high number of
genes were identiﬁed as differentially expressed, to limit the
false positives, we focused on the genes that were affected by
all three compounds. Together, these compounds altered the
expression of a common set of 205 genes, of which 173 were
repressed, and 32 activated (Tables 1 and S1).
Inhibition of HHQ and PQS coligand synthesis should
prevent MvfR activation, and consequently MvfR-dependent
gene regulation. To this end, the AA analogs were found to
signiﬁcantly reprogram MvfR-dependent gene expression,
including the suppression of several positively regulated loci
that direct HAQ synthesis, or the production of key virulence
factors. One hundred forty-four total PA14 genes are MvfR
dependent, with 122 positively and 22 negatively regulated
[25]. One hundred eleven (78%) of these loci were differ-
entially expressed in response to at least one of the AA
analogs (Table S2). Individually, 6FABA, 6CABA, and 4CABA
altered the expression of 54, 89, and 102 MvfR-dependent
loci, respectively (Table S2). Of the 122 positively regulated
MvfR-dependent genes, 56 have known functions, many of
which promote P. aeruginosa pathogenicity, including HAQ
production [25]. Indeed, all three AA analogs strongly
repressed the HAQ biosynthetic operons pqsA-E and phnAB
and the pyocyanin production–mediating operons phzABC-
Figure 1. Anthranilic Acid Analogs and HAQ Biosynthetic Pathway
(A) Chemical structures of AA, MA, and five halogenated AA analogs.
(B) The HAQ biosynthetic pathway and hypothetical steps mediated by the pqsA-D gene products.
doi:10.1371/journal.ppat.0030126.g001
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Inhibitors of MvfR Coligand Signal SynthesisDEFG, phzH, phzM, and phzS (Table S2). In addition, the
analogs inhibited several loci that direct the synthesis of
additional virulence-related factors, including hydrogen
cyanide (hcnABC), chitinase (chiC), lectins (lecA and lecB), and
elastase (lasB) [19,25,31,32,39,40]. Functional assays conﬁrmed
that the AA analogs effectively eliminated HAQ biosynthesis
(Figure 2) and pqsA-lacZ reporter gene expression (Figure
S2A), and signiﬁcantly reduced production of the MvfR-
dependent virulence factors, pyocyanin and elastase (Figure
S2B and S2C).
QS plays a critical role in the activation of virulence gene
expression in many pathogens, and Table 1 shows that the AA
analogs strikingly reprogrammed QS-dependent gene ex-
pression (also Table S1). Of the 173 common genes that were
Table 1. Summary of QS-Dependent and QS-Independent Genes That Are Repressed or Activated in Response to AA Analog
Treatment
6FABA 6CABA 4CABA Common
d Total
e
Genes Repressed by AA analogs mvfR-dependent
a 44 52 54 37 50
lasR/rhlR-dependent
b 83 118 120 67 117
Total QS-dependent
c 127 (49%) 170 (48%) 174 (50%) 104 (60%) 167 (43%)
Total QS-independent 134 180 173 69 223
Total genes repressed 261 350 347 173 390
Genes Activated by AA analogs mvfR-dependent
a 51 52 1 2 1 9
lasR/rhlR-dependent
b 14 24 28 8 33
Total QS-dependent
c 19 (20%) 39 (14%) 49 (14%) 10 (31%) 52 (14%)
Total QS-independent 74 229 287 22 300
Total genes activated 93 268 336 32 352
Total genes 354 618 683 205 742
Percentages in parentheses correspond to the number of differentially expressed QS-dependent genes divided by the total number of differentially expressed genes.
aIncludes both mvfR-dependent and lasR/rhlR-dependent genes, and mvfR-dependent and lasR/rhlR-independent genes.
blasR/rhlR-dependent and mvfR-independent.
cIncludes all mvfR-dependent and all lasR/rhlR-dependent genes.
dCommon genes that exhibit differential expression in response to all three AA analogs.
eTotal number of genes that exhibit differential expression in response to at least one of the AA analogs.
doi:10.1371/journal.ppat.0030126.t001
Figure 2. Halogenated AA Analogs Inhibit HAQ Biosynthesis
Culture supernatants of PA14 cells grown in LB media minus or plus 1.5 mM or 6 mM 6FABA, 1.5 mM or 6 mM 6CABA, 1.5 mM 4CABA, or 1.5 mM MA,
were collected at 5, 10, 15, and 24 h; and HHQ, PQS, and HQNO concentrations (mg/l) were quantified by LC/MS. Data points are the average of
triplicate experiments, 6 standard deviation. To facilitate presentation, below-detection levels of HAQs are indicated as 0.01.
doi:10.1371/journal.ppat.0030126.g002
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control [19,25,41,42], with 37 MvfR-dependent, and 67 solely
LasR- and/or RhlR-dependent. Similarly, of the 32 common
upregulated loci, 10 were QS dependent (Table 1). This broad
perturbation of QS-regulated gene expression further sug-
gested that the AA analogs should potentially limit P.
aeruginosa virulence.
Functional classiﬁcation of the 205 common genes that
were differentially expressed in response to all three of the
AA analogs revealed different sets of cell activities (unpub-
lished data). Speciﬁcally, the repressed genes were over-
represented for activities that include secreted factors, for
which the repressed genes strikingly account for almost 20%
of all such genes, adaptation and protection functions, such
as osmoprotection, and chemotaxis. In contrast, the activated
genes were overrepresented for activities that mediate the
general cellular machinery and contribute to the cell
metabolome. High resolution nuclear magnetic resonance
(NMR) analysis of PA14 cells grown minus and plus 4CABA
provided functional evidence that the AA analogs stimulate
the metabolome, as the assigned resonances for ATP, ADP,
and NAD peak resonances were all signiﬁcantly higher (p ,
0.05) in the 4CABA-treated cells (Figure S3 and Table S3).
Note that 6FABA, 6CABA, and 4CABA upregulated metab-
olome genes, which further demonstrated they did not inhibit
bacterial growth at the concentrations used.
PqsA as the Target for AA Analog Inhibition of HAQ
Production
Through what molecular target do the AA analogs restrict
HAQ synthesis? Figure 3A shows that AA accumulated in the
cell supernatants of PA14 cells grown in 6FABA, 6CABA, or
4CABA; accordingly, the antABC genes, which mediate AA
degradation, were strongly upregulated (Table S1). As such,
6FABA, 6CABA, or 4CABA did not restrict HAQ production
by inhibiting AA production via PhnAB or another AA
synthase. Instead, they most likely shut down HAQ synthesis
by competing with AA for the PqsA active site at the start of
the HAQ biosynthetic pathway (Figure 1B). To this end, pqsA
 
mutant cells also accumulated AA (Figure 3A, and [26]),
indicating that the analogs inhibited HAQ biosynthesis
activity that utilized AA. Also, exogenous AA partially
restored HHQ and PQS production in PA14 cells grown in
6FABA or 4CABA, but not in 6CABA (Figure 3B; unpublished
data). If the analogs do directly compete with AA, they should
also perturb tryptophan production, since TrpD, the initial
enzyme in the tryptophan biosynthesis pathway, utilizes AA as
a substrate. Indeed, these compounds inhibited cell prolifer-
ation in minimal media, and exogenous tryptophan rescued
this defect for the cells grown in 6FABA, or 6CABA, but not
4CABA (Figure S4A). Together, these results suggest that the
AA analogs inhibit HAQ production, and at least 6FABA and
6CABA inhibit tryptophan synthesis by respectively compet-
ing with AA for the PqsA and TrpD active sites.
6FABA, 6CABA, and 4CABA Limit P. aeruginosa Virulence
in Mice
The AA analogs should restrict P. aeruginosa virulence, as
they prevent the expression of MvfR-dependent virulence
genes. Indeed, these compounds limited P. aeruginosa viru-
lence in a thermal injury mice model, where mice were
burned and then infected (BþI) with PA14, and subsequently
administered with a single intravenous injection of each AA
analog at 6 h post-BþI. Figure 4A shows that while only 10%
of the uninjected BþI controls survived P. aeruginosa infection,
35%, 37%, and 50% of the mice treated with 6FABA, 6CABA,
and 4CABA, respectively, survived infection. In addition, the
kinetics of mortality was signiﬁcantly delayed in the treated
mice. As expected, reduced protection was seen for later
single injection post-BþI, and essentially no protection was
afforded by 24 h (unpublished data).
6FABA, 6CABA, and 4CABA Prevent In Vivo HHQ
Production, but Not Local Bacterial Proliferation
PA14 cells produce HHQ and PQS in the infection wound
site [23]. Figure 4B shows that the AA analogs strongly
inhibited this production. The injection of 6FABA or 6CABA
at 6 h post-BþI greatly limited in vivo HHQ levels at 12 h
post-BþI in rectus abdominus muscle that directly underlies
the infection site, versus comparable muscle from untreated
BþI mice. This reduction was not due to reduced PA14
proliferation, as the AA analogs did not alter bacterial CFU/
Figure 3. AA Analogs Compete with AA for the PqsA Active Site
(A) The AA analogs do not perturb AA accumulation. Intracellular AA concentrations (mM) were determined for PA14 cells grown minus or plus 1.5 mM
6FABA, 6CABA, or 4CABA, and for pqsA
  mutant cells.
(B) Exogenous AA partially overcomes AA analog inhibition of HHQ synthesis in PA14 cells. Increasing concentrations of AA were added to cultures
grown in 0.125 mM 6FABA, 0.75 mM 6CABA, or 0.125 mM 4CABA, which reduced HHQ production by 75% in supernatants of OD600¼4 cell cultures. The
competing AA concentrations were 0, 3, 6, and 10 times that of each AA analog.
doi:10.1371/journal.ppat.0030126.g003
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Although 4CABA was less effective in reducing in vivo HHQ
synthesis by 12 h than 6FABA or 6CABA, which could be
because the mice received 2.5-fold less 4CABA, it was a better
inhibitor of in vitro HAQ synthesis and of MvfR-dependent
gene expression than 6FABA or 6CABA. Nevertheless,
4CABA, even with a lower HAQ inhibitory efﬁcacy in vivo,
was capable of limiting infection over time similar to 6FABA
or 6CABA (Figure 4A).
HAQ Inhibitors Limit Systemic Bacterial Dissemination in
Infected Mice
PA14 cells inoculated intradermally into the midline crease
of the mouse burn eschar proliferate in the wound, invade
the intact underlying rectus abdominus muscle, and then
spread via the blood to infect adjacent muscle tissue [43,44].
This systemic dissemination, which is a signiﬁcant problem in
human P. aeruginosa infections, was greatly reduced in mice
injected with 6FABA, 6CABA, or 4CABA at 6 h post-BþI,
versus uninjected control mice. Figure 5A shows that the
bacterial counts in muscle at the infection site were statisti-
cally the same for treated and control mice, which further
conﬁrmed that the AA analogs did not restrict in vivo
bacterial proliferation. Conversely, Figure 5B shows that the
PA14 CFU/mg counts in adjacent muscle were 2–3 log units
lower in the experimental versus control animals, and Figure
5C shows that the blood bacterial counts were similarly
reduced. This inhibition of the systemic dissemination of
PA14 cells is likely a major component of the protective in
vivo anti-infective efﬁcacy of the AA analogs to limit PA14
pathogenesis. Note that this efﬁcacy is most likely due to
inhibition of virulence factor gene expression, versus
Figure 4. The AA Analogs Promote Survival of BþI Mice to PA14 Pathogenesis, and Restrict In Vivo HHQ Production
(A) PA14-infected mice were injected 6 h post-BþI with 6FABA, 6CABA, or 4CABA. Mice infected with pqsA
  cells served as an additional control group.
Data were averaged for a minimum of two independent experiments, with n(PA14)¼40; n(PA14/6FABA)¼36; n(PA14/6CABA)¼30; n(PA14/4CABA)¼
20 and n(pqsA
 ) ¼ 20. Standard deviations were ,20% for the time points between 0 and 4 d, and ,12% thereafter. Cox proportional hazards
regression showed that mouse mortality due to PA14 infection was significantly reduced by injection with 6FABA (hazard ratio ¼ 0.398, p ¼ 5.6e-04),
6CABA (hazard ratio ¼ 0.397, p ¼ 1.2e-03), and 4CABA (hazard ratio ¼ 0.325, P ¼ 1.8e-03), compared with control saline; pqsA
  virulence was highly
attenuated (hazard ratio ¼ 0.118, p ¼ 9.1e-06).
(B) HHQ levels (lg/mg) at 12 h post-BþI for rectus adbominus muscle directly underlying the infection site in untreated BþI mice, and for mice treated 6
h post-BþI with 6FABA, 6CABA, or 4CABA. n¼5 for each experimental condition. The t-test (p¼0.011) and Wilcoxon rank sum test (p¼0.03) showed
that the difference in HHQ levels between control and 4CABA-treated mice was statistically significant.
doi:10.1371/journal.ppat.0030126.g004
Figure 5. The AA Analogs Restrict Systemic Bacterial Proliferation, but Not Local Proliferation at the Infection Site
PA14-infected mice were left untreated (controls) or injected 6 h post-BþI with 6FABA, 6CABA, or 4CABA. The animals were subsequently sacrificed at 22
h post-BþI, and bacteria CFU/mg were determined for (A) muscle tissue that directly underlies the infection site; (B) muscle tissue adjacent to the
infection site; and (C) blood. Numbers above dots correspond to the number of mice for each condition. The statistical significance of the CFU/mg
differences between the treated and untreated control mice were determined using a Wilcoxon rank sum test. p-Values for the difference in adjacent
muscle in response to 6FABA, 6CABA, and 4CABA treatment versus no treatment were 0.00001, 0.00066, and 0.00267, respectively; p-values for the
difference in blood with 6FABA, 6CABA, and 4CABA, treatment versus no treatment were 0.00147, 0.00331, and 0.00331, respectively.
doi:10.1371/journal.ppat.0030126.g005
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proliferated and were as pathogenic as PA14 cells in the BþI
mice (unpublished data; Figure S4B), indicating that trypto-
phan inhibition was non-limiting for in vivo growth and
virulence.
Potential Broad-Spectrum Efficacy: The AA Analogs
Reduce HAQ Production and Heighten the
Osmosensitivity of Several Bacterial Pathogens
Other bacterial pathogens also likely utilize HAQ-based QS
signaling and HAQ congeners as virulence mediators. As
such, the AA analogs could have broad efﬁcacy as anti-
infective reagents against human pathogens beyond P.
aeruginosa via their inhibition of HAQ synthesis pathways.
To this end, both the highly virulent Gram-negative human
pathogen Burkholderia pseudomallei and its close relative B.
thailandensis encode functional homologs of the P. aeruginosa
pqsA-E operon [34] and produce unsaturated HAQs, including
HEHQ, NEHQ, and UDEHQ, plus lower levels of saturated
HAQs, including HHQ, but not PQS. [34]. Figure 6 shows that
3 mM 6FABA, 6CABA, and 4CABA effectively abolished B.
thailandensis HAQ synthesis.
Virulence genes encode a diversity of activities, several of
which permit pathogens to withstand hostile conditions in
the host environment, such as high osmolarity. Betaine, a key
bacterial osmoprotectant, is synthesized from betaine alde-
hyde via the betB gene product. PA14 cells grown in the
presence of 4CABA exhibited signiﬁcantly higher betaine
aldehyde levels versus control cells, as assessed by high
resolution NMR (Figure S3 and Table S3), correlating with the
lower betaine levels as determined by liquid chromatography/
mass spectrometry (LC/MS) and with the reduced betB
expression in the presence of AA analogs (unpublished data).
Figure 7 shows that 6 mM 6FABA, 6 mM 6CABA, and 1.5 mM
4CABA exposure caused PA14 cells to be far less resistant to
high salt, versus control cells. This heightened osmosensitivity
was not mediated via AA analog inhibition of AHL- or HAQ-
mediated QS, as wild-type, pqsA
 , and lasRrhlR
  mutant cells
were equally salt resistant, and betB expression is QS
independent. Instead, this effect was likely due to reduced
betaine levels, plus additional QS-independent factors, as
betB
  mutant cells were more sensitive to high salt than
control cells, but less so than cells grown in the presence of
AA analogs. Figure 7 also shows that the AA analogs,
especially 6CABA, similarly increased the osmotic sensitivity
of the Gram-negative bacteria B. thailandensis and Yersinia
pseudotuberculosis, and the Gram-positive bacteria Staphylococcus
aureus and Bacillus subtilis. Note that 4CABA was highly
effective in reducing the salt resistance of B. thailandensis, but
failed to affect the other tested pathogens. These osmopro-
tection results further suggest that the AA analogs could have
broad-spectrum anti-bacterial activity against pathogens
beyond P. aeruginosa.
Figure 6. The AA Analogs Inhibit HAQ Production in B. thailandensis Cell
Supernatants
Mass spectrometry (MS) determination of unsaturated HAQs in OD600¼3
culture supernatants of B. thailandensis cells grown in the absence or
presence of 3 mM 6FABA, 6CABA, or 4CABA. Note that while saturated
HAQs, including HHQ, occur in B. thailandensis cells, their levels were
below the quantification threshold.
doi:10.1371/journal.ppat.0030126.g006
Figure 7. The AA Analogs Increase the Osmotic Sensitivity of Several Bacterial Pathogens
Ten times (103) serial dilutions of the indicated bacterial pathogens were spotted onto high-salt tester plates containing no AA analog, 6 mM 6FABA, 6
mM 6CABA, or 1.5 mM 4CABA. Note that at these concentrations, bacterial growth on regular low-salt LB plates was unaffected.
doi:10.1371/journal.ppat.0030126.g007
PLoS Pathogens | www.plospathogens.org September 2007 | Volume 3 | Issue 9 | e126 1235
Inhibitors of MvfR Coligand Signal SynthesisDiscussion
Combating super pathogens with broad-spectrum resist-
ance may require new anti-infective compounds that selec-
tively interfere with pathways that mediate virulence without
affecting cell viability. Here we showed that three halogen-
ated AA analogs, 6FABA, 6CABA, and 4CABA, restricted P.
aeruginosa pathogenesis in mice by inhibiting the MvfR-
dependent QS system that regulates the expression of key
virulence genes. Signiﬁcantly, these compounds did not
perturb cell viability. Four principal results demonstrated
the anti-MvfR and anti-pathogenesis efﬁcacy of these AA
analogs: 1) they blocked in vivo and in vitro production of
HHQ and PQS, and consequently MvfR function; 2) they
disrupted the expression of MvfR-dependent virulence genes,
including pqsA-D, which mediate coligand synthesis; 3) they
increased host survival to P. aeruginosa infection; and 4) they
restricted systemic bacterial dissemination. These com-
pounds also inhibited HAQ synthesis in B. thailandensis and
restricted the production of several non-MvfR-dependent
metabolites, including the osmoprotectant betaine, which
may promote bacterial survival under harsh host conditions.
As such, these compounds could have a multifactorial effect
and possibly a broad-spectrum anti-infective activity against
several clinically signiﬁcant human pathogens.
How do the AA analogs disrupt MvfR coligand synthesis?
The pqsA gene product, which is closely related to coenzyme A
ligases that activate aromatic carbonyl compounds [37], is
thought to generate the HAQ quinoline backbone from AA
and a ß-keto fatty acid. Our hypothesis is that an electron-
withdrawing group could inhibit the formation of an
activated carbonyl such as a CoA ester, and our results
showed that indeed these halogenated AA analogs inhibited
HAQ synthesis. We propose that the halogenated analogs
compete with AA for the PqsA active site since AA
accumulates in PA14 cells grown in the presence of these
compounds to levels equivalent to those in pqsA
 mutant cells.
Furthermore, exogenous AA reversed 6FABA and 4CABA
inhibition of HAQ synthesis, suggesting that they reversibly
bind to PqsA. Conversely, AA did not reverse 6CABA
inhibition, which suggests that this compound is a non-
competitive inhibitor, has much higher PqsA afﬁnity, or has a
higher intracellular concentration versus 6FABA or 4CABA.
However, unless the PqsA enzyme is puriﬁed, it cannot be
determined whether AA analogs act on PqsA only through
such mechanisms, as it is also possible that the halogen atom
could interact with other PqsA residues either inside or close
to the active site.
The three compounds also had additional differences to
each other, including quantitative and qualitative effects on
gene expression, inhibition of osmoprotection, and restora-
tion of tryptophan auxotrophy to cells grown in 6FABA or
6CABA, but not in 4CABA. That 6CABA and 4CABA behave
differently—non-competitively in one assay and competi-
tively in another one—in rescuing HHQ synthesis and
tryptophan auxotrophy may be due to the fact that PqsA
and TrpD enzymes do not have any similarity in protein
sequence or domain structure. Therefore, it is possible that
these enzymes possess a different AA binding site. The
comparison of TrpD and PqsA crystal structures, when they
become available, might conﬁrm this. Nevertheless, all three
compounds strongly inhibited HHQ and PQS coligand
synthesis, and consequently MvfR-dependent gene regulation,
and reduced P. aeruginosa pathogenicity. Such effects require
that the concentrations of the AA analogs are in the mM
range, possibly due to at least either an intrinsic low afﬁnity
for the PqsA active site, a reduced ability to enter into the
cell, or because they are actively pumped out. If either of the
latter two cases occurs, a low concentration of the com-
pounds inside the cells is achieved.
The AA analogs reprogrammed MvfR-dependent and
MvfR-independent gene expression. This differential expres-
sion response demonstrated the efﬁcacy of the analogs to
disrupt MvfR regulon activation and their broader effect on a
large number of MvfR-independent loci. Of the 205 genes
affected by all three compounds, 173 were repressed, and 32
were activated. That the compounds altered the expression of
MvfR-independent loci, indicates they affect additional
regulatory pathways, and suggests a possible multifactorial
effect.
The mechanism by which AA analogs restrict pathogenicity
has not yet been demonstrated. We propose that their anti-
infective efﬁcacy is principally due to their inhibition of the
MvfR-dependent QS regulatory pathway, though we cannot
exclude a multifactorial effect. Interestingly, a single in-
jection of any of the compounds impacted the course of the
disease over days. Bacterial numbers and systemic dissem-
ination are major contributing factors to the potential
lethality of P. aeruginosa infection, especially in immunocom-
promised individuals. Indeed, while the AA analogs did not
alter bacterial proliferation at the infection site at 12 and 24
h, they signiﬁcantly lowered bacterial counts in adjacent
muscle tissue and prevented systemic spread. These effects,
which were not due to reduced tryptophan synthesis and/or
viability, likely resulted from inhibition of HAQs, at least up
to 12 h, which consequently impacted the expression of the
virulence factors dependent on their production, and thus
greatly aided the host’s ability to clear the infection. As such,
MvfR/HAQ inhibition is likely an important component of
the anti-infective efﬁcacy of the AA analogs in improving
mouse survival to P. aeruginosa infection.
Several plant and human pathogens, including Pseudomonas,
Bordetella, Burkholderia, Ralstonia, Streptomyces, Mycobacteria, and
the Archeae Sulfolobus, encode putative PqsA and MvfR
homologs, and in some cases, pqsBCD-like loci. It would be
of interest to determine whether these homologs mediate
HAQ production and promote virulence, and if so, whether
AA analogs also inhibit them. B. thailandansis and B.
pseudomallei, a potential biowarfare agent, carry functional
pqsA-D genes that direct HAQ synthesis [34], and we showed
that the AA analogs blocked B. thailandensis HAQ production.
These results suggest that the AA analogs may have anti-
infective efﬁcacy against bacterial pathogens beyond P.
aeruginosa. Furthermore, as virulence functions are often
encoded in bacterial pathogens by QS-dependent genes, the
effects of AA analogs on MvfR-independent QS-regulated
genes also suggests that they may have broad-spectrum
activity.
Although QS inhibitors can disrupt QS in vivo, to date, no
such compounds have been demonstrated to increase host
survival to P. aeruginosa infection [3]. We present here a new
class of QS inhibitors that blocked the expression of MvfR-
dependent virulence genes. These reagents are the ﬁrst
example of QS pathway inhibitors that restrict P. aeruginosa
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conﬁrmed the importance of the MvfR-dependent QS path-
way for P. aeruginosa virulence and demonstrated its utility as
a therapeutic target for selective anti-infective reagents.
Their potential as therapeutic molecules was further sup-
ported by the fact that the alternative pathways for AA
production, shikimate and tryptophan, are absent in humans.
In addition, the ability of AA analogs to restrict production of
MvfR-independent compounds, including betaine, could
further contribute to their anti-infective activity. Notably,
these compounds did not impede bacterial cell viability at the
site of infection. Furthermore, the presence of mvfR and
HAQ synthetic gene homologs in other bacterial pathogens,
together with the ability of AA analogs to increase the
osmosensitivity of several clinically signiﬁcant bacteria,
suggests that these compounds could be used to treat
infections caused by other bacterial pathogens besides P.
aeruginosa. It remains to be seen if these compounds cause any
signiﬁcant side effects. Nevertheless, they provide the basis
for the design and development of compounds that block the
MvfR regulatory pathway. Such reagents should have signiﬁ-
cant clinical utility in treating acute and chronic P. aeruginosa
infections, and possibly other bacterial pathogens.
Materials and Methods
Bacterial strains and growth conditions. The Rif
R P. aeruginosa
human clinical isolate UCBPP-PA14 [44], and its pqsA
 [26], lasRrhlR
 ,
(this study), trpC
 , trpE
 , and betB
  [45] isogenic mutant derivatives,
were grown at 37 8C on Luria Bertani (LB) agar plates, in LB broth, or
in minimal M9 medium plus 2 mM MgSO4, 0.4% glucose, and 0.1 mM
CaCl2.T h elasRrhlR
  double mutant was generated by allelic
exchange using the previously constructed single rhlR::Tc PA14 [25]
and lasR::Gm PA14 mutants [26]. B. thailandensis E264, S. aureus 8325,
and B. subtilis QPB467 were grown at 37 8C on LB agar or in LB broth,
and Y. pseudotuberculosis IP32953 was grown at 30 8C on LB agar or in
LB broth. One hundred lgm l
 1 rifampicin, 300 lgm l
 1 carbenicillin,
30 lgm l
 1 gentamycin, tetracycline (100 lg/ml), 1 mM tryptophan,
and different concentrations of AA were used as required.
AA analogs. For bacterial assays, a fresh solution of each
compound (Sigma-Aldrich, http://www.sigmaaldrich.com/) was pre-
pared in culture medium. For mice injections, fresh 20-mM solutions
of 6FABA or 6CABA were prepared in 0.9% NaCl, dissolved at 50 8C
for 30 min, and ﬁltered through 0.22-lm ﬁlters. For 4CABA, a 20-mM
solution in 50% ethanol was ﬁrst prepared, as 4CABA has a maximal
solubility of 3 mM in 0.9% NaCl.
PA14 growth. Overnight PA14 cultures were grown in LB minus or
plus AA analog and diluted the following day in fresh media minus or
plus compound. Bacterial growth kinetics were determined by
measuring OD600. The maximal concentrations that do not restrict
PA14 growth in LB were found to be 6 mM 6FABA, 6 mM 6CABA,
and 1.5 mM 4CABA. These concentrations were used in all
subsequent experiments, unless otherwise noted.
PpqsA-lacZ expression. Overnight cultures of PA14 and pqsA
  cells
harboring pGX5, which carries the PpqsA-lacZ reporter gene [27],
were diluted to OD600 0.05; and b-galactosidase activity, expressed as
Miller Units [46], and OD600 were measured at selected time points.
Assays were performed in triplicate.
Pyocyanin and elastase quantiﬁcation. Pyocyanin concentration
(lg/ml) was determined by measuring OD520 [47,48]. Elastase activity
was determined by measuring the OD495 of 1 ml of OD600¼4 culture
supernatant mixed with 10 mg of elastin congo red (Sigma-Aldrich),
following incubation at 37 8C for 3 h with agitation and centrifuga-
tion.
RNA isolation and transcriptome analyses. PA14 cells were grown
in 5 ml of LB at 37 8C with agitation minus and plus 6 mM 6FABA, 6
mM 6CABA, or 1.5 mM 4CABA. Triplicate samples of two
independent cultures for each AA analog were harvested at OD600
¼ 2.5, and total RNA was puriﬁed using the RNAeasy spin column
(Qiagen, http://www.qiagen.com/), and assayed using the GeneChip P.
aeruginosa Genome Array (Affymetrix, http://www.affymetrix.com/).
GeneChip expression. Affymetrix DAT ﬁles were processed using
the Affymetrix Gene Chip Operating System (GCOS) to create .cel
ﬁles. The raw intensity .cel ﬁles from the 12 chips, three replicates
each for four different conditions, were normalized by robust multi-
chip analysis (RMA) (Bioconductor release 1.7) with PM-only models.
Array quality control metrics generated by Affymetrix Microarray
Suite 5.0 were used to assess hybridization quality. Normalized
expression values were analyzed with SAM (Signiﬁcance Analysis of
Microarray) [49] using the permuted unpaired two-class test. The
control group consisted of sample replicates in the absence of AA
analogs. Each of the three experimental groups consisted of the AA
analog sample replicates. Genes whose transcript levels exhibited an
up or down absolute fold change .2, and q value ,6% in response to
all three analogs versus control were further analyzed. Functional
annotation for the differentially regulated genes is from http://v2.
pseudomonas.com/.
Statistics. The likelihood of overrepresentation of functional
categories in the upregulated or downregulated genes relative to
the background of all array genes was calculated using Fisher’s exact
test. The statistical signiﬁcance differences of PA14 CFU/mg between
experimental and control groups were calculated using the Wilcoxon
rank sum test. The statistical signiﬁcance differences in the
metabolome of PA14 cells grown in absence or presence of 4CABA
were calculated using the independent samples t-test (equal variances,
two-tailed; a ¼ 0.05). Signiﬁcance of survival kinetics was calculated
using Kaplan–Meier analysis with assessment of statistical signiﬁcance
using the Mantel–Cox log-rank test and Cox model. The statistical
signiﬁcance difference in HHQ levels in vivo between control and
treated mice was calculated using the t-test and Wilcoxon rank sum
test.
LC/MS. The quantiﬁcation of HAQs in bacterial culture super-
natants and in infected mouse tissue was performed as described
[23,50]. The HAQs were separated on a C18 reverse-phase column
connected to a triple quadrupole mass spectrometer, using a water/
acetonitrile gradient [50]. Positive electrospray in MRM mode with 2
3 10
 3 mTorr argon and 30 V as the collision gas and energy was
employed to quantify HAQs, using the ion transitions HHQ 244.159,
HHQ-D4 248.163, HQNO 260.159, PQS 260.175, and PQS-D4
264.179. B. thailandensis HAQs were assessed as above. The
pseudomolecular ions of each compound were monitored in full
scan mode, using the unsaturated PA14 HAQ response factors.
High-resolution magic angle spinning proton nuclear magnetic
resonance. PA14 cells were grown in triplicate minus or plus 1.5 mM
4CABA to OD600 ¼ 3. The culture samples were centrifuged and the
pellets were washed with ice cold PBS, resuspended in 100 ll of 75%
prewarmed ethanol, and sonicated. Four hundred ll of 75%
prewarmed ethanol was added and the samples were incubated at
100 8C for 4 min. Bacterial debris were removed by centrifugation,
and the supernatants were dried in a SpeedVac (Thermo Scientiﬁc,
http://www.thermo.com/) and dissolved in 100 mM phosphate pre-
pared with D2O. An aliquot of 10–20 ll of each sample was pipetted
into a 4-mM rotor with a spherical insert, and 10–20 llD 2O
containing 50 mM TSP (trimethylsilyl propionic-2,2,3,3-d4 acid, Mw¼
172, d ¼ 0 ppm) was added to provide the deuterium lock and
external chemical shift references, respectively. High-resolution
magic angle spinning proton nuclear magnetic resonance (HRMAS
1H NMR) was performed on a Bruker BioSpin (http://www.
bruker-biospin.com/) Avance NMR spectrometer (proton frequency
at 600.13 MHz, 89-mm vertical bore) using a 4-mM triple resonance
(
1H,
13C,
2H) HRMAS probe (Bruker). Temperature was maintained at
4 8C by a BTO-2000 unit in combination with a MAS pneumatic unit
(Bruker). The MAS speed was stabilized at 4.0 6 0.001 kHz by a MAS
speed controller. One dimensional
1H NMR spectra were acquired
for all the samples using a rotor-synchronized Carr-Purcell-Mei-
boom-Gill (CPMG) spin echo pulse sequence, (908-(t-1808-t)n-acquis-
ition), which works as a T2 ﬁlter to remove the spectral broadening.
The inter-pulse delay (t) was synchronized to the MAS speed of 250
ls. The number of transients was 256 with 32,768 (32 k) data points. A
line-broadening apodization function of 1.0 Hz was applied to all
HRMAS
1H FIDs prior to Fourier transformation. Metabolite
chemical shifts were according to Bundy et al. [51] and Chauton et
al. [52].
Mouse mortality. The animal protocol was approved by the
Massachusetts General Hospital Institutional Animal Care and Use
Committee. A thermal injury mouse model [43] was used as described
previously [44] to assess bacterial pathogenicity in 6-wk-old CD1 mice
(Charles River Laboratories, http://www.criver.com/). Following mouse
anesthetization, a full-thickness thermal burn injury involving 5%–
8% of the body surface area was produced on the dermis of the
shaved abdomen, and an inoculum of 5310
5 PA14 cells was injected
intradermally into the burn eschar. To assess the anti-infective
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received a single IV injection of 100 ll of 20 mM 6FABA (12 lg/g body
weight), 100 ll of 20 mM 6CABA (13.6 lg/g), or 40 ll of 20 mM 4CABA
(5.4 lg/g). Note that these compounds were injected at 6 h post-BþI
because HHQ and PQS were not detected in vivo at that time point.
Mice received a lower dose of 4CABA, as they appeared disoriented
when a higher amount was used. Such an effect may be due to the fact
that 4CABA was dissolved in EtOH instead of saline, which was used
for both 6FABA and 6CABA. Mice survival was subsequently assessed
over 7 d. Experiments were repeated at least in duplicate. Mice
infected with pqsA
  mutant cells, whose virulence was attenuated in
BþI mice versus PA14 cells [25], served as additional controls. Note
that injection of each of the compounds tested is nontoxic.
P. aeruginosa local and systemic proliferation in mice. Four sets of
BþI mice were burned and infected with PA14. Three of these sets
were injected 6 h post-infection with 6FABA, 6CABA, or 4CABA, with
the uninjected mice serving as controls. Five to 12 mice from each set
were sacriﬁced at 12 or 22 h post-BþI, and blood samples and tissue
biopsies of rectus abdominus muscle directly underlying the infection
site, or adjacent to this site, were collected for quantiﬁcation of
bacterial CFU/mg tissue. Blood samples of 50 llo r5ll were
immediately plated on agar, muscle tissue was homogenized in 2 ml of
PBS, and serial dilutions were plated on LB Rif plates. Following 24 h
incubation at 37 8C, PA14 CFU were determined. Note that although
bacteria can directly invade muscle that closely underlies the
infection site, they require systemic delivery via the blood to infect
adjacent muscle.
Osmotic stress. Starting from OD600¼3 bacterial cultures, a series
of six 10-fold dilutions were spotted onto high-salt LB agar tester
plates minus AA analog, or plus 6 mM 6FABA, 6 mM 6CABA, or 1.5
mM 4CABA. Concentrations of 0.9 M, 0.6 M, and 0.7 M NaCl were
respectively used to osmotically stress P. aeruginosa; B. thailandensis;
and S. aureus, B. subtilis, and Y. pseudotuberculosis cells. Plates were read
after overnight incubation. Note that the compounds do not perturb
bacterial growth under the low osmotic conditions of regular LB
plates.
Supporting Information
Figure S1. Growth Kinetics of PA14 in Response to 6FABA, 6CABA,
4CABA, or MA
Found at doi:10.1371/journal.ppat.0030126.sg001 (89 KB PDF).
Figure S2. The AA Analogs 6FABA, 6CABA, and 4CABA Inhibit (A)
Transcription from pqsA-E Promoter, (B) Pyocyanin, and (C) Elastase
Production
Data are average of triplicate experiments 6 SD. Three independent
experiments were performed.
Found at doi:10.1371/journal.ppat.0030126.sg002 (171 KB PDF).
Figure S3. The 600-MHz HRMAS
1H NMR Spectra of PA14 Cell
Samples Grown in the Presence or Absence of 1.5 mM 4CABA
The
1H chemical shift assignments are labeled as 0, TSP; 1, lipids/
macromolecules; 2, lactate; 3, alanine; 4, acetate; 5, glutamate; 6,
glutamine; 7, lysine; 8, histidine; 9, choline; 10, betaine aldehyde; 11,
glycine; 12, amino acid; 13, betaine aldehyde; 14, residual water; 15, C/
UXP; 16, ADPþATP; 17, C/UXP; 18, NAD; 19, ADPþATP; and 20–23,
NAD.
Found at doi:10.1371/journal.ppat.0030126.sg003 (56 KB PDF).
Figure S4. Tryptophan Deﬁciency Does Not Contribute to the
Analog-Mediated Decreased P. aeruginosa Virulence in Mice
(A) Growth kinetics of PA14 in minimal medium in the presence or
absence of 6 mM 6FABA, 6 mM 6CABA, or 1.5 mM 4CABA plus or
minus 1 mM tryptophan.
(B) Virulence of PA14 wild-type, and trpE
 , and trpC
  mutants in the
BþI model.
Found at doi:10.1371/journal.ppat.0030126.sg004 (165 KB PDF).
Table S1. Differential Expression Ratios of Genes that Are Positively
and Negatively Regulated in Response to 6FABA, 6CABA, and 4CABA
Found at doi:10.1371/journal.ppat.0030126.st001 (484 KB DOC).
Table S2. Differential Expression Levels of MvfR Positively and
Negatively Regulated Genes in Response to 6FABA, 6CABA, or
4CABA
Found at doi:10.1371/journal.ppat.0030126.st002 (297 KB DOC).
Table S3. Levels of Prominent
1H HRMAS MR Spectra Metabolite
Peaks in PA14 Cells Minus or Plus 4CABA Treatment
Found at doi:10.1371/journal.ppat.0030126.st003 (50 KB DOC).
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